1,195 results on '"Shea, Lonnie D."'
Search Results
52. Localized immune tolerance from FasL-functionalized PLG scaffolds
53. Contributors
54. Nanotechnology and biomaterials for immune modulation and monitoring
55. It’s All in the Delivery: Designing Hydrogels for Cell and Non-viral Gene Therapies
56. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells
57. Evaluation of biomaterial scaffold delivery of IL-33 as a localized immunomodulatory agent to support cell transplantation in adipose tissue
58. Ligands, Receptors, and Transcription Factors that Mediate Inter-Cellular and Intra-Cellular Communication during Ovarian Follicle Development
59. High Frequency Spectral Ultrasound Imaging to Detect Metastasis in Implanted Biomaterial Scaffolds
60. Cancer nanomedicine for combination cancer immunotherapy
61. An engineered niche delineates metastatic potential of breast cancer
62. Building‐Block Size Mediates Microporous Annealed Particle Hydrogel Tube Microenvironment Following Spinal Cord Injury
63. Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates
64. Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance
65. Phosphate regulates chondrogenesis in a biphasic and maturation-dependent manner
66. Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis
67. An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy
68. Synergy of Paracrine Signaling During Early-Stage Mouse Ovarian Follicle Development In Vitro
69. Biodegradable nanoparticles targeting circulating immune cells reduce central and peripheral sensitization to alleviate neuropathic pain following spinal cord injury
70. Semi-automated counting of axon regeneration in poly(lactide co-glycolide) spinal cord bridges
71. Extracellular matrix mediators of metastatic cell colonization characterized using scaffold mimics of the pre-metastatic niche
72. Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization
73. Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets
74. Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation
75. Dynamic genome-scale cell-specific metabolic models reveal novel inter-cellular and intra-cellular metabolic communications during ovarian follicle development
76. Biodegradable nanoparticles targeting circulating immune cells reduce central and peripheral sensitization to alleviate neuropathic pain following spinal cord injury.
77. An engineered niche delineates metastatic potential of breast cancer.
78. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
79. Fig. S3 from Metastatic Conditioning of Myeloid Cells at a Subcutaneous Synthetic Niche Reflects Disease Progression and Predicts Therapeutic Outcomes
80. Data from Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo
81. Supplementary Data File S3 from Metastatic Conditioning of Myeloid Cells at a Subcutaneous Synthetic Niche Reflects Disease Progression and Predicts Therapeutic Outcomes
82. Supplementary Data from Metastatic Conditioning of Myeloid Cells at a Subcutaneous Synthetic Niche Reflects Disease Progression and Predicts Therapeutic Outcomes
83. Data from Metastatic Conditioning of Myeloid Cells at a Subcutaneous Synthetic Niche Reflects Disease Progression and Predicts Therapeutic Outcomes
84. Supplementary Data from Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo
85. Supplementary Figures S1-S6 from Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo
86. Supplementary Table S1 from Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo
87. Data from Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo
88. Supplementary Methods and References from Enhanced Survival with Implantable Scaffolds That Capture Metastatic Breast Cancer Cells In Vivo
89. Controlled release strategies for modulating immune responses to promote tissue regeneration
90. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance
91. Poly(lactide-co-glycolide) microspheres for MRI-monitored delivery of sorafenib in a rabbit VX2 model
92. Harnessing nanoparticles for immune modulation
93. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries
94. Take a deep breath and digest the material: organoids and biomaterials of the respiratory and digestive systems
95. Multi-modal magnetic resonance elastography for noninvasive assessment of ovarian tissue rigidity in vivo
96. Primate Follicular Development and Oocyte Maturation In Vitro
97. Membrane‐coated nanoparticles for direct recognition by T cells
98. Fas Ligand-Modified Scaffolds Protect Stem Cell Derived β-Cells by Modulating Immune Cell Numbers and Polarization
99. Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation
100. Heparin–chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.